Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07652905
What this trial is testing

CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia (PCL)
Institute of Hematology & Blood Diseases Hospital, China 24
Early research (Phase 1)Study completedNCT04047290
What this trial is testing

AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 80
Testing effectiveness (Phase 2)Looking for participantsNCT06951646
What this trial is testing

CtDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Who this might be right for
Non Small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University 70
Testing effectiveness (Phase 2)Study completedNCT05214482
What this trial is testing

AK112 in Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 154
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Testing effectiveness (Phase 2)Ended earlyNCT00452140
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 40
Early research (Phase 1)Looking for participantsNCT06803680
What this trial is testing

BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
BeOne Medicines 90
Testing effectiveness (Phase 2)Study completedNCT01730638
What this trial is testing

ImmunoTEP for Patients With Medullary Thyroid Carcinoma.

Who this might be right for
Medullary Thyroid Carcinoma
Nantes University Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06799611
What this trial is testing

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)Treatment
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableNo Longer AvailableNCT05462639
What this trial is testing

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer
Early research (Phase 1)Study completedNCT00185081
What this trial is testing

Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging

Who this might be right for
Colonic Neoplasms
Radboud University Medical Center 42
Early research (Phase 1)Looking for participantsNCT06150157
What this trial is testing

JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 300
Early research (Phase 1)Looking for participantsNCT06126666
What this trial is testing

A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
ABL Bio, Inc. 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Early research (Phase 1)Looking for participantsNCT07545122
What this trial is testing

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

Who this might be right for
Triple Negative Breast Cancer (TNBC)Colorectal CancerUrothelial Cancer
Context Therapeutics Inc. 162
Testing effectiveness (Phase 2)WithdrawnNCT06361758
What this trial is testing

Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT05955508
What this trial is testing

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 40
Early research (Phase 1)Study completedNCT03340766
What this trial is testing

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Amgen 31
Early research (Phase 1)Ended earlyNCT00014560
What this trial is testing

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Dartmouth-Hitchcock Medical Center 3
Early research (Phase 1)Looking for participantsNCT05357651
What this trial is testing

Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）

Who this might be right for
Solid TumorLymphoma
L & L Bio Co., Ltd., Ningbo, China 100
Next Page